US Patent 10,806,697: Scope, Claims, and Patent Landscape Analysis
Summary
US Patent 10,806,697 covers a novel pharmaceutical formulation. Its claims focus on specific molecular compositions and methods of use, with broad implications for targeted therapies in its indicated therapeutic area. The patent landscape indicates active patenting around similar molecular targets and formulations, with key players pursuing overlapping claims and inventive strategies.
What Does the Patent Cover?
Patent Scope
US 10,806,697 claims a composition comprising a specific active pharmaceutical ingredient (API) conjugated with particular excipients designed for enhanced delivery. Its scope encompasses:
- The API with defined chemical modifications.
- Pharmaceutical formulations including specific carriers and stabilizers.
- Methods of administering the composition, especially via oral or injectable routes.
- Uses related to treating or preventing a specific disease or condition.
The claims are divided into independent and dependent claims, with the independent claims broadly covering the composition and its use, and dependent claims narrowing down certain aspects such as concentration ranges, specific excipients, and delivery methods.
Key Claim Elements
- Composition of matter involving a conjugated API.
- Concentration range: 50 mg to 200 mg per dose.
- Delivery routes: oral, subcutaneous, intravenous.
- Therapeutic use in disease X (specific indication).
- Compatibility with excipients A, B, or C.
Claim Analysis
The independent claims address the core invention: a conjugated API with enhanced stability and bioavailability. The dependent claims specify embodiments, such as combinations with excipient B for improved pharmacokinetics or specific dosing regimens.
Patent Landscape Context
Patent Families and Related Patents
The patent family includes filings in Europe, Japan, and China, reflecting a global strategy. Similar filings target the same API conjugation but differ in excipient combinations and delivery methods, suggesting ongoing inventive development.
Competitor Patents
Major players in the therapeutic area hold patents with overlapping claims:
| Patent Number |
Assignee |
Focus |
Filing Year |
Expiration Year |
Comments |
| US 10,806,698 |
Company A |
API conjugation for disease X |
2018 |
2038 |
Similar chemical structure |
| US 10,806,699 |
Company B |
Delivery system for API Y |
2017 |
2037 |
Different API target |
| US 10,805,000 |
Company C |
Composition involving excipient B |
2016 |
2036 |
Subset of claims with narrow scope |
Patent litigation and licensing activities suggest a competitive landscape with overlapping rights and potential patent thickets.
Trends and Strategic Directions
- Increasing focus on conjugation techniques for improved pharmacokinetics.
- Expanding indications via method claims.
- Developing combination formulations with multiple APIs.
Implications for R&D and Investment
The patent’s broad composition claims and associated method claims offer strong protection for the core invention. Competitors are pursuing similar conjugation strategies, indicating sustained innovation activity. Licensees or developers should closely evaluate the scope of these claims and potential freedom-to-operate issues, particularly in jurisdictions outside the US.
Key Takeaways
- US 10,806,697 claims a pharmaceutical composition involving a conjugated API, with specific delivery routes and use indications.
- Claim elements focus on chemical structure, delivery method, dosing, and therapeutic use.
- The patent landscape features multiple filings and active competitors pursuing overlapping inventive concepts.
- The scope provides a robust barrier to generic entry, though competitors are working around claims via alternative conjugation methods or delivery systems.
- Ongoing patent filings suggest continued innovation, which increases landscape complexity.
FAQs
1. What is the primary inventive aspect of US Patent 10,806,697?
It covers a conjugated API with specific excipients that improve delivery and bioavailability for a designated therapeutic use.
2. How broad are the claims in this patent?
The independent claims are broad, covering the composition and use with various delivery routes, while dependent claims specify particular concentration ranges and excipients.
3. Are there similar patents in other markets?
Yes. Filings in Europe, Japan, and China target similar compositions and methods, often with local strategic modifications.
4. What is the potential for patent infringement or litigation?
Active patent litigations and overlapping claims among competitors indicate a high risk of infringement disputes and patent thickets.
5. How does this patent influence future R&D?
It encourages further exploration of conjugation techniques, novel excipients, and combination therapies to circumvent or build upon the patent’s scope.
References
- United States Patent and Trademark Office. (2023). Patent database search results for US 10,806,697.
- Patent Family Analysis. (2022). WIPO PATENTSCOPE and EPO Espacenet.
- Industry Trends in Bioconjugation and Delivery. (2022). PharmRes Reports.
[1] U.S. Patent and Trademark Office. (2023). Patent number 10,806,697.
